Physician
Oncology
Dr. Shane P. Dormady, MD
|
|
Give Review
Shane Dormady practices Oncology. She went to NYU School of Medicine. She received 1 awards: "Top MD". Shane Dormady is also a published MD. She has 8 publication published. The most recent publication is: The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer. Shane Dormady accepts Medicare.
Publications
- The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.
- Use of urine flow cytometry to verify relapse of Burkitt's lymphoma in the genitourinary system.
- Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue.
- Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment.
- mVH1, a dual-specificity phosphatase whose expression is cell cycle regulated.
- Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors.
- Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6).
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- Top MD
Education
-
Stanford University -
Duke University Hospital -
NYU School of Medicine
Hospital
-
Good Samaritan Hospital -
Sequoia Hospital -
Stanford Health Care -
El Camino Hospital
Drug Facts
| NPI NUMBER | 1417024654 | |
| NPPES Provider LastName | DORMADY | |
| NPPES Provider FirstName | SHANE | |
| NPPES Provider ZIPCode | 950080259 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 2057.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 250.0 | |
| Percent Opioid Claims | 12.15 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417024654 |
| Last Name Of The Provider | DORMADY |
| First Name Of The Provider | SHANE |
| View All |
Similar Doctors
|
Dr. Edmund Tai, MD
 This Doctor is OpenDoctor Recommended.
|